WHO ICTRP trial
The pharmacogenetics of vitamin D response in tuberculosis - The…
EUCTR2010-023189-27-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-023189-27-GB |
|---|---|
| Public title | The pharmacogenetics of vitamin D response in tuberculosis - The pharmacogenetics of vitamin D response in tuberculosis |
| Scientific title | The pharmacogenetics of vitamin D response in tuberculosis - The pharmacogenetics of vitamin D response in tuberculosis |
| Primary sponsor | University of Birmingham |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Tuberculosis |
| Interventions | Trade Name: Cholecalciferol (Dekristol capsules) Product Name: Dekristol® 20,000IU Pharmaceutical Form: Capsule* INN or Proposed INN: cholecalciferol CAS Number: 67970 Concentration unit: IU international unit(s) Concentration type: equal… |
| Registration date | Nov 23, 2010 |
| Target size | 160 |
| Secondary IDs | RG-10-179;n/a |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: